Global Hospital-Acquired Disease Testing Market Research Report 2024(Status and Outlook)
Report Overview:
Hospital acquired infections/diseases (HAIs) or nosocomial infections are defined to the infection acquired by patients during their stay in healthcare settings. Approximately 9.2 out of 100 patients in the U.S. acquire HAI. The most common types of HAIs include pneumonia, urinary tract infection, bloodstream infection, surgical site infection and others. HAIs are caused by pathogens among patients with compromised immune system, and negligence by hospital staff. The significant morbidity and mortality, the associated management costs and growing pressure from governing bodies have urged care-givers to devise accurate diagnosis of HAIs for efficient healthcare provision.
The Global Hospital-Acquired Disease Testing Market Size was estimated at USD 522.01 million in 2023 and is projected to reach USD 707.58 million by 2029, exhibiting a CAGR of 5.20% during the forecast period.
This report provides a deep insight into the global Hospital-Acquired Disease Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hospital-Acquired Disease Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hospital-Acquired Disease Testing market in any manner.
Global Hospital-Acquired Disease Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Diatherix Laboratories
Gen-Probe
Qiagen
F. Hoffmann-La Roche
Cepheid
Life Technologies Corporation
Meridian Biosciences
Cantel Medical Corporation
Nordion
Market Segmentation (by Type)
UTI Testing
SSI Testing
Pneumococcal Infections Testing
Bloodstream Infections Testing
MRSA Testing
Market Segmentation (by Application)
Small and Medium Sized Hospitals
Large Sized Hospitals
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Hospital-Acquired Disease Testing Market
Overview of the regional outlook of the Hospital-Acquired Disease Testing Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hospital-Acquired Disease Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Hospital-Acquired Disease Testing
- 1.2 Key Market Segments
- 1.2.1 Hospital-Acquired Disease Testing Segment by Type
- 1.2.2 Hospital-Acquired Disease Testing Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Hospital-Acquired Disease Testing Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Hospital-Acquired Disease Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
- 2.1.2 Global Hospital-Acquired Disease Testing Sales Estimates and Forecasts (2019-2030)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Hospital-Acquired Disease Testing Market Competitive Landscape
- 3.1 Global Hospital-Acquired Disease Testing Sales by Manufacturers (2019-2024)
- 3.2 Global Hospital-Acquired Disease Testing Revenue Market Share by Manufacturers (2019-2024)
- 3.3 Hospital-Acquired Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Hospital-Acquired Disease Testing Average Price by Manufacturers (2019-2024)
- 3.5 Manufacturers Hospital-Acquired Disease Testing Sales Sites, Area Served, Product Type
- 3.6 Hospital-Acquired Disease Testing Market Competitive Situation and Trends
- 3.6.1 Hospital-Acquired Disease Testing Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Hospital-Acquired Disease Testing Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Hospital-Acquired Disease Testing Industry Chain Analysis
- 4.1 Hospital-Acquired Disease Testing Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Hospital-Acquired Disease Testing Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Hospital-Acquired Disease Testing Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Hospital-Acquired Disease Testing Sales Market Share by Type (2019-2024)
- 6.3 Global Hospital-Acquired Disease Testing Market Size Market Share by Type (2019-2024)
- 6.4 Global Hospital-Acquired Disease Testing Price by Type (2019-2024)
- 7 Hospital-Acquired Disease Testing Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Hospital-Acquired Disease Testing Market Sales by Application (2019-2024)
- 7.3 Global Hospital-Acquired Disease Testing Market Size (M USD) by Application (2019-2024)
- 7.4 Global Hospital-Acquired Disease Testing Sales Growth Rate by Application (2019-2024)
- 8 Hospital-Acquired Disease Testing Market Segmentation by Region
- 8.1 Global Hospital-Acquired Disease Testing Sales by Region
- 8.1.1 Global Hospital-Acquired Disease Testing Sales by Region
- 8.1.2 Global Hospital-Acquired Disease Testing Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Hospital-Acquired Disease Testing Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Hospital-Acquired Disease Testing Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Hospital-Acquired Disease Testing Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Hospital-Acquired Disease Testing Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Hospital-Acquired Disease Testing Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Diatherix Laboratories
- 9.1.1 Diatherix Laboratories Hospital-Acquired Disease Testing Basic Information
- 9.1.2 Diatherix Laboratories Hospital-Acquired Disease Testing Product Overview
- 9.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Product Market Performance
- 9.1.4 Diatherix Laboratories Business Overview
- 9.1.5 Diatherix Laboratories Hospital-Acquired Disease Testing SWOT Analysis
- 9.1.6 Diatherix Laboratories Recent Developments
- 9.2 Gen-Probe
- 9.2.1 Gen-Probe Hospital-Acquired Disease Testing Basic Information
- 9.2.2 Gen-Probe Hospital-Acquired Disease Testing Product Overview
- 9.2.3 Gen-Probe Hospital-Acquired Disease Testing Product Market Performance
- 9.2.4 Gen-Probe Business Overview
- 9.2.5 Gen-Probe Hospital-Acquired Disease Testing SWOT Analysis
- 9.2.6 Gen-Probe Recent Developments
- 9.3 Qiagen
- 9.3.1 Qiagen Hospital-Acquired Disease Testing Basic Information
- 9.3.2 Qiagen Hospital-Acquired Disease Testing Product Overview
- 9.3.3 Qiagen Hospital-Acquired Disease Testing Product Market Performance
- 9.3.4 Qiagen Hospital-Acquired Disease Testing SWOT Analysis
- 9.3.5 Qiagen Business Overview
- 9.3.6 Qiagen Recent Developments
- 9.4 F. Hoffmann-La Roche
- 9.4.1 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Basic Information
- 9.4.2 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product Overview
- 9.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product Market Performance
- 9.4.4 F. Hoffmann-La Roche Business Overview
- 9.4.5 F. Hoffmann-La Roche Recent Developments
- 9.5 Cepheid
- 9.5.1 Cepheid Hospital-Acquired Disease Testing Basic Information
- 9.5.2 Cepheid Hospital-Acquired Disease Testing Product Overview
- 9.5.3 Cepheid Hospital-Acquired Disease Testing Product Market Performance
- 9.5.4 Cepheid Business Overview
- 9.5.5 Cepheid Recent Developments
- 9.6 Life Technologies Corporation
- 9.6.1 Life Technologies Corporation Hospital-Acquired Disease Testing Basic Information
- 9.6.2 Life Technologies Corporation Hospital-Acquired Disease Testing Product Overview
- 9.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Product Market Performance
- 9.6.4 Life Technologies Corporation Business Overview
- 9.6.5 Life Technologies Corporation Recent Developments
- 9.7 Meridian Biosciences
- 9.7.1 Meridian Biosciences Hospital-Acquired Disease Testing Basic Information
- 9.7.2 Meridian Biosciences Hospital-Acquired Disease Testing Product Overview
- 9.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Product Market Performance
- 9.7.4 Meridian Biosciences Business Overview
- 9.7.5 Meridian Biosciences Recent Developments
- 9.8 Cantel Medical Corporation
- 9.8.1 Cantel Medical Corporation Hospital-Acquired Disease Testing Basic Information
- 9.8.2 Cantel Medical Corporation Hospital-Acquired Disease Testing Product Overview
- 9.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Product Market Performance
- 9.8.4 Cantel Medical Corporation Business Overview
- 9.8.5 Cantel Medical Corporation Recent Developments
- 9.9 Nordion
- 9.9.1 Nordion Hospital-Acquired Disease Testing Basic Information
- 9.9.2 Nordion Hospital-Acquired Disease Testing Product Overview
- 9.9.3 Nordion Hospital-Acquired Disease Testing Product Market Performance
- 9.9.4 Nordion Business Overview
- 9.9.5 Nordion Recent Developments
- 10 Hospital-Acquired Disease Testing Market Forecast by Region
- 10.1 Global Hospital-Acquired Disease Testing Market Size Forecast
- 10.2 Global Hospital-Acquired Disease Testing Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Hospital-Acquired Disease Testing Market Size Forecast by Country
- 10.2.3 Asia Pacific Hospital-Acquired Disease Testing Market Size Forecast by Region
- 10.2.4 South America Hospital-Acquired Disease Testing Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Hospital-Acquired Disease Testing by Country
- 11 Forecast Market by Type and by Application (2025-2030)
- 11.1 Global Hospital-Acquired Disease Testing Market Forecast by Type (2025-2030)
- 11.1.1 Global Forecasted Sales of Hospital-Acquired Disease Testing by Type (2025-2030)
- 11.1.2 Global Hospital-Acquired Disease Testing Market Size Forecast by Type (2025-2030)
- 11.1.3 Global Forecasted Price of Hospital-Acquired Disease Testing by Type (2025-2030)
- 11.2 Global Hospital-Acquired Disease Testing Market Forecast by Application (2025-2030)
- 11.2.1 Global Hospital-Acquired Disease Testing Sales (K Units) Forecast by Application
- 11.2.2 Global Hospital-Acquired Disease Testing Market Size (M USD) Forecast by Application (2025-2030)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook